AI in Clinical Trials Market to Reach USD 7.32 Billion by 2034 as AI Reshapes Patient Recruitment, Data Analysis and Drug Development, says Maximize Market Research
Why now
Thesis: AI adoption in trials supports long-run biopharma efficiency
Catalyst to watch: Adoption by major pharma sponsors
Main risk: Sponsored forecast may overstate near-term adoption
Why it matters
AI adoption in clinical trials could cut drug-development costs and timelines, benefiting biopharma productivity.
Details
PUNE, India, Sept. 25, 2026 /PRNewswire/ -- The Global AI in Clinical Trials Market was valued at USD 2 Billion in 2025 and is projected to grow at a 15.5% CAGR from 2026 to 2034, reaching USD 7.32 Billion by 2034, according to Maximize Market Research. Global AI in Clinical Trials Market...
Related assets & topics
IndiaHealthcareAISources
- prnewswire · 2026-09-25 22:15 UTC